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Background: Abnormal and uncontrolled proliferation of lung fibroblasts may contribute to pulmonary fibrosis.
Lipopolysaccharide (LPS) can induce fibroblast proliferation and differentiation through activation of
phosphoinositide3-Kinase (PI3-K) pathway. However, the detail mechanism by which LPS contributes to the
development of lung fibrosis is not clearly understood. To investigate the role of phosphatase and tensin homolog
(PTEN), a PI3-K pathway suppressor, on LPS-induced lung fibroblast proliferation, differentiation, collagen secretion
and activation of PI3-K, we transfected PTEN overexpression lentivirus into cultured mouse lung fibroblasts with or
without LPS treatment to evaluate proliferation by MTT and Flow cytometry assays. Expression of PTEN, alpha-smooth
muscle actin (alpha-SMA), glycogen synthase kinase 3 beta (GSK3beta) and phosphorylation of Akt were determined by
Western-blot or real-time RT-PCR assays. The PTEN phosphorylation activity was measured by a malachite green-based
assay. The content of C-terminal propeptide of type I procollagen (PICP) in cell culture supernatants was examined
by ELISA.
Results: We found that overexpression of PTEN effectively increased expression and phosphatase activity of PTEN, and
concomitantly inhibited LPS-induced fibroblast proliferation, differentiation and collagen secretion. Phosphorylation of
Akt and GSK3beta protein expression levels in the LPS-induced PTEN overexpression transfected cells were significantly
lower than those in the LPS-induced non-transfected cells, which can be reversed by the PTEN inhibitor, bpV(phen).
Conclusions: Collectively, our results show that overexpression and induced phosphatase activity of PTEN inhibits
LPS-induced lung fibroblast proliferation, differentiation and collagen secretion through inactivation of PI3-K-Akt-GSK3beta
signaling pathways, which can be abrogated by a selective PTEN inhibitor. Thus, expression and phosphatase activity of
PTEN could be a potential therapeutic target for LPS-induced pulmonary fibrosis. Compared with PTEN expression level,
phosphatase activity of PTEN is more crucial in affecting lung fibroblast proliferation, differentiation and collagen secretion.
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Various acute lung injuries (ALI) can develop into acute
respiratory distress syndrome (ARDS) with diffuse pulmon-
ary fibrosis [1-3], which may result in respiratory failure [4].
Occurrence of ALI and ARDS can be due to exposure to li-
popolysaccharides (LPSs), endotoxins produced by Gram-
negative bacteria. Previous studies have found that focal
aggregation of lung fibroblasts occurred prior to forma-
tion of fibrosis [5], implying that aberrant proliferation of
fibroblasts takes place in the early stages of ALI/ARDS.
Pulmonary fibrosis is characterized by fibroblast prolifera-
tion and differentiation to myofibroblast that are respon-
sible for production of collagen [6,7]. Our previous studies
have shown that LPS was able to directly induce secre-
tion of collagen in primary cultured mouse lung fibro-
blasts via Toll-like receptor 4 (TLR4)-mediated activation
of the phosphoinositide3-kinase-Akt (PI3-K-Akt) pathway
[8,9]. LPS was also reported to induce fibroblasts prolifer-
ation [10], down-regulate phosphatase and tensin homo-
log (PTEN) expression [11,12].
The PTEN gene is recognized as a tumor suppressor
with dephosphorylation activity [13]. Downregulation of
PTEN expression and suppression of its dephosphoryla-
tion activity induce proliferation and inhibit apoptosis of
glioma cells through activation of the PI3-K-Akt-glycogen
synthase kinase 3 (GSK3) pathway, suggesting that PTEN
may be involved in inactivation of PI3-K signaling [14].
PTEN restoration was also related to the inhibition of dif-
ferentiation of human lung fibroblasts into myofibroblasts
through extracellular signal-related kinase (ERK)/Akt inhib-
ition [15]. The negative regulatory role of PTEN on the
PI3-K-Akt pathway suggests that, without LPS stimulation,
PTEN prevents the proliferation of lung fibroblasts, and
that overexpression of PTEN might abrogate the fibroblast
proliferation, differentiation, activation of PI3-K-Akt-GSK3β
and collagen secretion induced by LPS. Thus, the mechan-
ism by which PTEN is directly involved in LPS-induced
fibroblast proliferation through regulation of the PI3-K-
Akt-GSK3β pathway requires further elucidation.
In the present study we investigated the role of PTEN
in LPS-induced lung fibroblast proliferation differenti-
ation and collagen secretion, and explored the potential
mechanism by which overexpression of PTEN inhibits
LPS-induced lung fibroblast proliferation, differentiation,
activation of PI3-K-Akt-GSK3 pathways and collagen
secretion.
Results
PTEN expression and dephosphorylation activity in
mouse lung fibroblasts transfected with Pten
overexpression lentivirus
In the Pten-transfected primary cultured mouse lung fi-
broblasts, overexpression of PTEN and changes in PTEN
dephosphorylation activity was detected by measuringPten mRNA through real-time PCR and PTEN protein
via Western blot. Malachite green-based assay was used
to measure the PTEN dephosphorylation activity.
Levels of Pten mRNA and PTEN protein, and the de-
phosphorylation activity of PTEN, were significantly re-
duced in the EmptyLPS group (cells transfected with the
empty vector and treated with LPS), compared with the
cells transfected with the empty vector but without LPS
(Empty group). These levels were significantly increased
in the PTENLPS group (Pten-transfected cells treated with
LPS) 72 h after LPS challenge (p < 0.05), compared to the
EmptyLPS group. This indicates that LPS inhibited PTEN
expression in non-transfected control cells, and that the
PTEN lentiviral overexpression vector effectively increased
PTEN expression in the transfected primary mouse lung
fibroblasts (Figure 1A).
In Pten-transfected cells treated with LPS, treatment
with the PTEN inhibitor 1 μM bpV(phen) 72 h after the
LPS challenge(PTENLPS/bpV(phen) group) significantly re-
duced PTEN dephosphorylation activity, but had no ef-
fect on Pten mRNA and PTEN protein expression levels,
compared to Pten-transfected cells treated with LPS but
without the PTEN inhibitor(PTENLPS group, Figure 1B, C).
This shows that bpV(phen) inhibited PTEN dephosphory-
lation activity, but had no effect on mRNA and protein
expression.
Effect of PTEN overexpression on activation of
PI3-K-Akt-GSK3β pathway
To explore the detail mechanism underlying the effect of
PTEN activity on LPS-induced lung fibroblast prolifera-
tion, activation of PI3-K-Akt-GSK3β and collagen secre-
tion, we next tested the role of PTEN on activation of the
PI3-K-Akt-GSK3β pathway in the LPS-induced fibroblast
proliferation as assessed by Western blot. Compared to
groups that were not treated with LPS (i.e., transfected
with the empty vector [Empty group] or Pten-transfected
but given no other treatments [PTEN group]), cells of the
EmptyLPS group (transfected with the empty vector and
treated with LPS) showed a significant increase in phos-
phorylation of Akt (Ser473) and GSK3β expression 72 h
after LPS treatment (p < 0.05, both). Therefore, treatment
with LPS increased Akt phosphorylation and GSK3β ex-
pression. However, in the Pten-transfected cells treated
with LPS (PTENLPS group), the phosphorylation of Akt
and GSK3β expression was significantly reduced compared
with LPS-treated cells that were transfected with the empty
vector (EmptyLPS group, p < 0.05), and was comparable to
groups that were not given the LPS treatment (i.e., Pten-
transfected [PTEN group] or transfected with an empty
vector [Empty group], p > 0.05; Figure 2A-B). Thus, the
overexpression of PTEN abrogated the effect of the LPS.
Most notably, in the Pten-transfected cells treated with
LPS and the PTEN inhibitor bpV(phen)(PTENLPS/bpV(phen)
Figure 1 (See legend on next page.)
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Figure 1 Expression and dephosphorylation activity of PTEN in lung fibroblasts transfected with PTEN overexpression lentivirus. The
total RNA and cellular protein were collected from lung fibroblasts transfected with PTEN overexpression lentivirus (5 × 104 TU/mL) for 48 h and
treated with bpV(phen)(1 μM) for 0.5 h before exposure of the cells to 1 μg/mL LPS for up to 72 h, followed by detecting PTEN mRNA, protein
expression and dephosphorylation activity by real-time RT-PCR (1A), Western blot (1B) and Malachite green-based assay (1C). *p < 0.05 vs. Blank
and Empty group; †p < 0.05 vs. PTEN group; ‡p < 0.05 vs. PTENLPS group. Columns represent mean values and error bars represent SD. Blots are
representative of three independent experiments.
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was significantly increased 72 h after LPS treatment, com-
pared with those given the same treatments but without
bpV(phen)( PTENLPS group), and in fact was no different
from the cells transfected with the empty vector and
treated with LPS (EmptyLPS group, p > 0.05; Figure 2A-B).
In addition, we showed that treatment of Ly294002,
the specific PI3-K-Akt inhibitor, in Pten-transfected
cells could enhance the inhibition effect of PTEN on
GSK3β expression with or without LPS treatment (PTEN
group vs. PTENLy294002 group or PTENLPS group vs.
PTENLPS/Ly294002 group, p < 0.05; Figure 2B). This further
demonstrated that downregulation of GSK3β was induced
through inhibition of PI3-K-Akt pathway.
Collectively, these results above indicated that overex-
pression of PTEN inhibited LPS-induced lung fibroblast
proliferation by inhibiting PI3-K-Akt-GSK3β pathway.Effect of PTEN overexpression on LPS-induced
fibroblast proliferation
To investigate the effect of PTEN overexpression on LPS-
induced fibroblast proliferation, the MTT assay and flow
cytometry were performed. Our results showed that, com-
pared to the cells that were not Pten-transfected (Empty
group), cell proliferation (viability) and the number of
cells in S phase were significantly higher in those treated
with LPS (EmptyLPS group), 72 h after treatment (p <
0.05; Figure 3A-C). However, in the Pten-transfected
cells treated with LPS (PTENLPS group), cell proliferation
(viability) and the S phase cell ratio was significantly re-
duced 72 h after LPS was administered, compared with
the LPS-treated cells transfected with the empty vector
(EmptyLPS group), but was virtually the same as both the
Pten-transfected and empty vector-transfected cells that
were not treated with the LPS (PTEN group and Empty
group, p > 0.05; Figure 3A-C).
In Pten-transfected cells treated with LPS and the PTEN
inhibitor bpV(phen) (PTENLPS/bpV(phen) group), cell prolif-
eration (viability) and the S phase cell ratio were signifi-
cantly greater after bpV(phen) was given 72 h after LPS
treatment, compared with identically treated cells that did
not receive PTEN inhibitor (PTENLPS group). However,
these amounts were similar to those of the cells transfected
with the empty vector and treated with LPS (EmptyLPS
group, p > 0.05; Figure 3A-C).In comparisons between Pten-transfected cells treated or
not with the specific PI3-K-Akt inhibitor Ly294002, it was
found that application of Ly294002 significantly decreased
cell proliferation (viability) and the S phase cell ratio of lung
fibroblasts. This significant decrease was also shown be-
tween Pten-transfected cells treated with LPS, with or with-
out Ly294002 (PTENLy294002 group vs. PTENLPS/Ly294002
group; Figure 3A-C). The above results are strong evi-
dence that the expression and activity of PTEN has an im-
portant role in the inhibition of LPS-induced fibroblast
proliferation.Effect of PTEN overexpression on LPS-induced fibroblast
differentiation and collagen secretion
To investigate the effect of PTEN overexpression on LPS-
induced fibroblast differentiation and collagen secretion,
the expression of alpha smooth muscle actin (α-SMA), the
symbol of lung fibroblast-to-myofibroblast differentiation
[6], were detected by Western blot; And the content of
C-terminal propeptide of type I procollagen (PICP), a
segment degraded from the C-terminal by the procolla-
gen C-endopeptidase and a marker of type I collagen se-
cretion [16], in cell culture supernatants was examined
by ELISA.
Similar to PTEN overexpression on LPS-induced fibro-
blast proliferation, LPS treatment could increase the ex-
pression of α-SMA in lung fibroblast and levels of PICP in
cell culture supernatants, which could be overcame by
PTEN overexpression. The application of Ly294002 aggra-
vated the inhibition effect of PTEN, while the treatment of
bpV(phen) overcome this (p < 0.05, Figure 4A-B).Discussion
It is generally accepted that LPS-induced pulmonary fibro-
sis involves the proliferation and differentiation of lung fi-
broblasts [17,18]. PTEN, a tumor suppressor, is involved in
the proliferation of various cells [19-23]; a decrease in
PTEN expression results in the activation of the PI3-K-Akt
signaling pathway [24]. Therefore, further study exploring
the mechanism by which PTEN influences LPS-induced
lung fibroblast proliferation and differentiation has import-
ant clinical implications. Our results in the present study
indicate that LPS-induced downregulation of PTEN is dir-
ectly involved in fibroblast proliferation, differentiation
and collagen secretion by way of the PI3-K-Akt-GSK3β
Figure 2 The effect of PTEN overexpression on activation of PI3-K-Akt-GSK3β pathway in lung fibroblasts. Cellular protein was collected
from lung fibroblasts treated with 1 μM bpV(phen) for 0.5 h before exposure of the cells to LPS and transfected with PTEN overexpression vector
for up to 72 h. Afterwards, the total and phosphor-Akt (Ser473) (2A) and GSK3β (2B) were detected by Western Blot. *p < 0.05 vs. Blank and
Empty group; †p < 0.05 vs. PTEN group; ‡p < 0.05 vs. PTENLPS group.
§p < 0.05 vs. PTEN group; ||p < 0.05 vs. PTENLPS group. Columns represent mean
values and error bars represent SD. Blots are representative of three independent experiments.
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PTEN. This suggests that PTEN may be a potential inter-
vention target for pulmonary fibrosis.
A mutation or deletion in PTEN have been confirmed
to affect various cell biological behaviors [25,26] includ-
ing proliferation [19-23] collagen metabolism [27] andoncogenesis [28]. In our study, PTEN expression and its
dephosphorylation activity were inhibited when cells were
stimulated with LPS; the underlying mechanism remains
unclear but may be correlated with LPS-induced activa-
tion of transcription factors such as c-Jun, NF-κB, and
HES-1 [24,29-31]. This needs to be studied further.
Figure 3 (See legend on next page.)
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Figure 3 The effect of PTEN overexpression on proliferation of LPS-induced lung fibroblasts. The effect of overexpression of PTEN on lung
fibroblast proliferation at 72 h after 1 μg/mL LPS challenge was detected using MTT and Flow cytometry assays (3A, MTT assay. 3B and 3C, Flow
cytometry assay). bpV(phen)(1 μM for 0.5 h) was examined to investigate the effect of overexpression of PTEN on lung fibroblast proliferation.
PI3-K inhibitor Ly294002 (50 μmol/L for 1 h) was used to assess the effect of PTEN overexpression and PI3-K-Akt pathway inhibition on lung fibroblast
proliferation in the presence or absence of LPS. *p < 0.05 vs. Blank and Empty group; †p < 0.05 vs. PTEN group; ‡p < 0.05 vs. PTENLPS group.
§p < 0.05 vs.
PTEN group; ||p < 0.05 vs. PTENLPS group. Columns represented mean values and error bars represented SD. Flow cytometry graphs shown in Figure B
were representative of three independent experiments.
Figure 4 The effect of PTEN overexpression on differentiation and collagen secretion of LPS-induced lung fibroblasts. Cellular expression of
α-SMA examined by Western blot (A) and PICP content in cell culture supernatants detected by ELISA (B) were used to reflect the effect of overexpression
of PTEN on lung fibroblast differentiation and collagen secretion 72 h after 1 μg/mL LPS challenge. bpV(phen)(1 μM for 0.5 h) was used to investigate the
effect of overexpression of PTEN on lung fibroblast differentiation and collagen secretion. PI3-K inhibitor Ly294002 (50 μmol/L for 1 h) was used to assess
the effect of PTEN overexpression and PI3-K-Akt pathway inhibition on lung fibroblast differentiation and collagen secretion in the presence or absence of
LPS. *p< 0.05 vs. untreated control group; †p< 0.05 vs. PTEN group; ‡p< 0.05 vs. PTENLPS group.
§p< 0.05 vs. PTEN group; || p< 0.05 vs. PTENLPS group.
Columns represent mean values and error bars represent SD (Mean±SD). Blots are representative of three independent experiments.
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and its knockout through RNA interference [33] increased
cell proliferation and collagen metabolism [27], as did de-
phosphorylation of its protein product [34]. Our results in
the present study further showed that LPS-induced cell
proliferation, differentiation and collagen secretion could be
inhibited in lung fibroblasts transfected with a PTEN over-
expression lentivirus, which increased both PTEN levels
and its dephosphorylation activity. Similar results using a
PEP-1-PTEN fusion protein transfected into macrophages
[35] or adenovirus-mediated PTEN gene transferred into
synovial fibroblasts [36] were reported. Therefore, we
reasoned that a decrease in PTEN expression and its de-
phosphorylation activity could be directly involved in
inhibiting LPS-induced lung fibroblast cell proliferation,
differentiation and collagen secretion, and overexpres-
sion of PTEN may have potential for pulmonary fibrosis
treatment. This finding would be strengthened if in vivo
model, such as PTEN KO or transgenic mice, were used
to further confirm this.
The loss of PTEN, activation of the PI3-K-Akt signaling
pathway, or both is associated with cancer cell proliferation
and metastasis [14,37-39]. Protein products of the PTEN
gene can inactivate PI3-K activity with its dephosphoryla-
tion activity [40]. We previously showed that blockade
of PI3-K using a pharmacological inhibitor (Ly294002) de-
creased lung fibroblast collagen secretion [41]. As a down-
stream molecule of PI3-K-Akt, GSK3β is also involved
in cell growth and other cell cycle-related biological
functions [42-44]. Activation or phosphorylation of GSK3β
was found to be a factor in LPS-induced or TLR4-mediated
pro-inflammatory cytokine production in immune cells
[45-47]. In the current study, we found that overexpression
of PTEN enhanced the inhibitory effect of Ly294002 on cell
growth, differentiation and collagen secretion concomitant
with suppression of phosphorylation of Akt. Our results
also suggested that activation of GSK3β was involved in the
LPS-induced lung fibroblast proliferation, differentiation
and collagen secretion. Considering GSK3β was found to
be an important downstream molecule of PI3-K-Akt in our
previous studies [48] and that of others [49], we reasoned
that the activation of PI3-K-Akt-GSK3β complex signal-
ing pathways played important role in mediating the LPS-
induced lung fibroblast proliferation, differentiation and
collagen secretion.
Thus, we think that LPS could activate the PI3-K-Akt-
GSK3β signaling pathway by inhibiting PTEN expression
and dephosphorylation activity, thereby promoting fibro-
blast proliferation, differentiation and collagen secretion.
In fact, we show that the PTEN inhibitor bpv(phen),
which inhibited PTEN dephosphorylation activity and had
no effect on its expression [50], overcame the effect of
LPS. This suggests that expression of PTEN and PTEN
dephosphorylation activity may have a causal associationwith the activity status of the PI3-K-Akt-GSK3β pathway
during LPS-induced lung fibroblast proliferation, differen-
tiation and collagen secretion.
Our present study showed that lentiviral-mediated PTEN
overexpression inhibited activation of the PI3-K-Akt path-
way and lung fibroblast proliferation, differentiation and
collagen secretion, with or without LPS-stimulation. How-
ever, these changes could be reversed by treatment with
the PTEN dephosphorylation activity inhibitor, bpv (phen).
This implies that the dephosphorylation activity of PTEN
is more crucial in the regulation of lung fibroblast func-
tions than PTEN expression. These findings were in accord
with one study using lung cancer cells [51]. More exper-
iments using PTEN short interfering RNA (siRNA) are
required to further confirm the role of PTEN in affect-
ing lung fibroblast functions. In addition, whether LPS-
induced Akt phosphorylation or GSK3β expression is
the major cause of fibroblast proliferation needs to be
determined. Other studies have shown that TSC-2 [52],
PRAS40 [53], mTORC [54], GSK3 [55] and FOXO [56]
are involved in the phosphorylation of Akt, cell prolifer-
ation, and survival pathways. Thus, further determining
the role of Akt using Akt siRNA or GSK3β siRNA in
lung fibroblast proliferation may be required.
In addition, Akt is also an important anti-apoptotic
and pro-survival kinase during the cellular response to
cell injury. It is possible that the inhibition of lung fibro-
blast proliferation is in part a consequence of increased
cell apoptosis. But, we have not found any significant
apoptotic changes in lung fibroblast after LPS treatment
in present study (data not shown). Therefore, more ex-
periments are needed to confirm this in the future.Conclusions
Collectively, we show that PTEN is an important negative
regulator of pathogenesis of pulmonary fibrosis induced by
LPS. Our extended work has confirmed that PTEN de-
phosphorylation activity and inactivation of the PI3-K-
Akt-GSK3β signaling pathways are important in inhibiting
the growth and differentiation of lung fibroblasts. Overex-
pression and induced phosphatase activity of PTEN inhibit
LPS-induced lung fibroblast proliferation, differentiation
and collagen secretion through inactivation of PI3K-Akt-
GSK3β pathways; thus, expression and phosphatase activ-
ity of PTEN could be a potential therapeutic target for
LPS-induced pulmonary fibrosis.Materials and methods
Ethics statement
All procedures of this study were carried out in accord-
ance with the guidelines for animal care published by
the United States’ National Institutes of Health (NIH) for
animal care (Guide for the Care and Use of Laboratory
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Publication No. 86–23, revised 1985).
Primary cultures of mouse lung fibroblasts
Lung fibroblasts were isolated from a C57/BL6 mouse as
described in our previous study [41]. Briefly, an eight-week-
old mouse (Shanghai SLAC Laboratory Animal, China) was
euthanized by decapitation. Lung tissues were promptly ex-
cised, washed with phosphate buffered saline (PBS), and cut
to 1 mm3 pieces. The tissues were distributed evenly over
the bottom of culture plates and covered with Dulbecco’s
modified Eagle’s medium (DMEM) containing 10% calf
serum (Gibco, USA). The plates were cultured at 37°C in a
humidified 5% CO2 incubator (Labotect, Germany), and
DMEM was changed every three days. When the cultures
reached 80% confluence, adherent cells were detached by
exposure to 0.25% trypsin for five minutes, and then pas-
saged at a dilution of 1:4. Cells grew to a typical fusiform
shape after four generations. Fibroblasts were characterized
as previously described [57], and then used for the follow-
ing experiments.
Construction and identification of Pten
overexpression lentivirus
A Pten overexpression lentivirus was constructed and veri-
fied by GeneChem (Shanghai, China). The Pten gene was




products were inserted into the pGC-LV vector through
restriction enzyme Age I linearization, and then the con-
struction vector which carried the Pten gene fragment was
transformed into DH5α competent cells. These were cul-
tured at 37°C for 16 h. Positive clones containing the Pten
coding sequence were selected by PCR. The vector con-
taining the correct Pten sequence was named pGC-FV-
Pten. In accordance with the method described by the
GeneChem lentiviral operating manual, pGC-FV-Pten,
pHelper 1.0, and pHelper 2.0 were transferred into 293 T
cells. The recombinant virus was harvested and quantified.
Experimental design and treatment
Purified mouse lung fibroblasts in DMEM containing 10%
calf serum were seeded into 96-well plates and grown in
a humidified atmosphere containing 5% CO2. When cells
reached ~60% confluence, the medium was replaced with
serum-free medium and the cultures were incubated for an
additional 24 h at 37°C in 5% CO2. Finally, the serum-free
medium was replaced with DMEM containing 10% calf
serum and the cells were divided into several groups for
various experimental manipulations as described below.
To augment levels of PTEN in the lung fibroblasts, the
Pten overexpression lentivirus was added to cells at aconcentration of 5 × 104 transducing units (TU)/mL for
48 h prior to any other treatments. The PTENLPS group
was then incubated with 1 μg/mL LPS (derived from
O55:B5 Escherichia coli; Sigma, USA) for up to 72 h. To
assess the effect of PTEN overexpression and PI3-K-Akt
pathway inhibition on LPS-induced lung fibroblast pro-
liferation, the Pten-transfected group PTENLPS/Ly294002
was established by adding 50 μmol/L of the PI3-K in-
hibitor Ly294002 (CST, USA) to transfected cells for 1 h,
followed by incubating with 1 μg/mL LPS for up to 72 h.
To inhibit the dephosphorylation activity of PTEN, Pten-
transfected lung fibroblasts (PTENLPS/bpV(phen) group) were
exposed to the PTEN inhibitor potassium bisperoxo (1,10-
phenanthroline) oxovanadate (bpV[phen]; 1 μM; Alexis,
USA) for 30 min. Afterwards, cells were incubated with
1 μg/mL LPS for up to 72 h.
Group PTEN consisted of transfected cells that were
not given any other treatment. To establish group PTE
NLy294002, the transfected cells were treated with 50 μmol/
L Ly294002 for 1 h without any other treatments. Group
PTENbpV(phen) consisted of Pten-transfected cells that
were given 1 μM bpV(phen) stimulation without LPS.
Negative controls were established by adding the same
volume of control-lentivirus (i.e., containing no exogen-
ous gene) for 48 h, and incubating the fibroblasts with
(group EmptyLPS) or without (group Empty) LPS for 72 h.
Cells of group Blank received no treatments.
Experiments were performed in triplicate in each group.
Cells were collected for measurements 72 h with or without
LPS stimulation. Cell proliferation was assessed by the
MTT assay and flow cytometry. The expressions of PTEN
protein and phosphorylated Akt were examined by Western
blot analysis. PTEN dephosphorylation activity was mea-
sured with a malachite green-based assay for inorganic
phosphate [58].
Real-time RT-PCR
The mRNA expression of Pten was analyzed via real-
time RT-PCR. Total RNA was isolated from cells with
an RNeasy kit using Trizol (Invitrogen, USA) and was
reverse-transcribed into cDNA with a reverse transcription
kit using M-MLV polymerase (Promega, USA). Sequence-
specific primers were: glyceraldehyde 3-phosphate de-
hydrogenase (GAPDH)-F: 5′- TGGTGAAGGTCGGTGT
GAAC-3′, GAPDH-R: 5′-GCTCCTGGAAGATGGTGAT
GG-3′; Pten-F: 5′-CCATAACCCACCACAGC-3′, Pten -
R: 5′-AGTCCGTCCCTTTCCAG-3′. Real-time PCR was
performed in an IQ5 PCR System (Bio-Rad, USA) with an
initial denaturing step at 95°C for 15 s, 45 cycles of de-
naturing at 95°C for 5 s, and annealing at 60°C for 30 s.
Relative expression of real-time PCR products was de-
termined using the ΔΔCt method [59] to normalize tar-
get gene expression to that of the housekeeping gene
(GAPDH).
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Cell proliferation was evaluated by a modified MTT assay.
The test cells in exponential growth were plated at a final
concentration of 2 × 103 cells/well in 96-well culture plates
for different culture time. MTT (10 μl, 10 mg/mL) was
then added. After an additional 4 h of incubation, the re-
action was terminated by removal of the supernatant and
addition of 150 μl DMSO for 30 min. Optical density
(OD) of each well was measured at 490 nm using ELISA
reader (ELx808 Bio-Tek Instruments, USA).
Flow cytometry assay
As an indicator of cell proliferation, Flow cytometry was
performed to assess the relative percentages of cells at
different phases in the cell cycle. Cells were harvested
72 h after LPS stimulation, fixed in 70% alcohol for 1 h
at 4°C, permeabilized by incubation with PBS containing
0.2% Tween 20 at 37°C for 15 min, and incubated in PBS
with 50 μg/mL propidium iodide (P4170, Sigma, USA)
and 10 μg/mL RNase (EN0531, Fermentas, CA) for 1 h at
37°C. The fluorescence of 106 cells was analyzed on BD
FACSCalibur™ instruments (BD Biosciences, USA). G1, S,
and G2/M ratios were calculated using CellQuest Pro
Software (version 5.1, BD Biosciences, USA).
Western blot analysis
Expressions of PTEN, Ser473 phospho-Akt, GSK3β and
α-SMA were detected by Western blot. Briefly, cells were
collected and lysed with 1 × RIPA lysis Buffer (50 mM
Tris–HCl, pH 7.4, 150 mM NaCl, 1% Nonidet P-40, 0.5%
deoxycholic acid, 0.1% sodium dodecyl sulfate [SDS], 5 mM
ethylenediaminetetraacetic acid [EDTA], 2 mM phenyl-
methylsulfonyl fluoride [PMSF], 20 μg/mL aprotinin, 20
μg/mL leupeptin, 10 μg/mL pepstanin A, and 150 mM
benzamidine) on ice for 10–15 min. Cell debris was
pelleted by centrifugation, and protein-containing su-
pernatants were collected. Protein quantification was
performed with the bicinchoninic acid method, and SDS-
polyacrylamide gel electrophoresis (PAGE) was performed.
Proteins were transferred to polyvinylidene fluoride mem-
branes, probed with the appropriate primary and second-
ary antibodies, and detected by the ECL + plus™ Western
blotting system kit (Amersham, USA). Primary antibod-
ies (1:1000 dilution) were: rabbit anti-phospho-Akt (Ser
473; CST, USA), rabbit anti-Akt (CST, USA), rabbit anti-
PTEN CST, USA), rabbit anti-phosphor-GSK3β (Ser9)
(CST, USA), rabbit anti-α-SMA (Abcam, UK) and mouse
anti-GAPDH (Santa Cruz Biotechnologies, USA). Second-
ary antibodies (1:5000) were: goat anti-mouse IgG (Santa
Cruz Biotechnologies, USA) and goat anti-rabbit IgG (Santa
Cruz Biotechnologies, USA). Immunoreactivity was vis-
ualized with Perfection 3490 photo gel imaging systems
(Epson, Japan) and analyzed by Image Pro PLUS. Protein
expression was normalized to GAPDH.Malachite green-based assay
The specific hydrolysis of phosphate at the 3 position
on the inositol ring of diC16-phosphatidylinositol 3, 4,
5-triphosphate (PIP3) by PTEN was detected using a mal-
achite green-based assay for inorganic phosphate. Reactions
were carried out in a volume of 20 μL for various times
at 37°C, then terminated by the addition of 20 μL of 0.1 M
n-ethylmaleimide and 50 μL of malachite green reagent as
described previously [58]. The absorbance at 620 nm was
measured, and phosphate release quantified, by comparison
to a standard curve of KH2 PO4 (1–1000 pM). Reactions
were carried out in triplicate and the specific activities are
represented as moles of phosphate released per min/per
mole of enzyme, ± standard deviation (SD).
ELISA of PICP
The concentration of PICP in cell culture supernatant,
directly associated with type I procollagen synthesis, was
measured by ELISA using mouse PICP ELISA kit (Biorbyt,
UK.). All produces were carried out in accordance with
operating instruction.
Statistical analysis
All data are represented as mean ± SD. SPSS statistical
software version 12.0 was used for mean value compari-
sons of single-factor multiple samples. The homogeneity of
variance data were analyzed with the one-factor analysis of
variance least squares difference test, and the heterogeneity
of variance data were analyzed with the Kruskal Wallis
rank sum test. P-values < 0.05 were considered statistically
significant.
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